Antigen-Driven but Not Lipopolysaccharide-Driven IL-12 Production in Macrophages Requires Triggering of CD40

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 359-366

  DeKruyff, Rosemarie H ^a   Gieni, Randy S ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; HEMOCYANIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; DBA MOUSE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; ANTIGENS, CD40; HEMOCYANIN; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; OVALBUMIN; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030639620     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
2. Scott, P., and S. H. E. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12:346.
3. + T cell clones. Semin. Immunol. 5:421.
4. Gieni, R. S., X. Yang, and K. T. Hayglass. 1993. Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen. J. Immunol. 150:302.
5. Scott, B., R. Liblau, S. Degermann, L. Marconi, L. Ogata, A. Caton, H. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73.
6. + T cell clones: requirement for interleukin 4 and low molecular weight B cell growth factor. J. Exp. Med. 170: 1477.
7. + helper T cells: new insights into the regulation of IgE synthesis and into the pathogenesis of allergic disease. Pediatr. Asthma Allergy Immunol. 6:1.
8. Scott, P., E. Pearce, A. W. Cheever, R. L. Coffman, and A. Sher. 1989. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:161.
9. Romagnani, S. 1994. Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 6:838.
10. + T cells. J. Cell. Biochem. 18D:353.
11. + T cells. I. Influence of antigen concentration and antigen-presenting cell type. J. Immunol. 149:3468.
12. + cells from allergic individuals is modulated by allergen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
13. Srocktnger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891.
14. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
15. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
16. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A. S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
17. Chan, S. H., M. Kobayashi, D. Santoli, B. Perussia, and G. Trinchieri. 1992. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/ IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148:92.
18. + T cells through an effect on antigen-presenting cells. J. Immunol. 154:2578.
19. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
20. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type I immune response. J. Exp. Med. 177:1797.
21. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
22. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and McConnell. 1993. Soluble CD40 Ligand can replace the normal T cell-derived CD40 Ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209.
23. Clayberger, C. R., R. H. DeKruyff, J. Aisenberg, and H. Cantor. 1983. Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells. J. Exp. Med. 157:1906.
24. + T cells. J. Exp. Med. 182:1591.
25. Shu, U., M. Kiniwa, C. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125.
26. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370.
27. Kubin, M., J. Chow, and G. Trinchieri. 1993. Differential regulation of interleukin-12, tumor-necrosis factor-α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847.
28. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to inycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181:1015.
29. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/interieukin-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
30. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin-12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiological antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
31. + T lymphocytes. J. Immunol. 154:1523.
32. + T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J. Immunol. 156:3133.
33. Dune, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
34. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
35. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
36. + T cells. J. Immunol. 151:2497.
37. Hino, A., and H. Nariuchi. 1996. Negative feedback mechanism suppresses interleukin-12 production by antigen-presenting cells interacting with T helper 2 cells. Eur. J. Immunol. 26:623.
38. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:147.
39. Klaus, S. J., I. Berberich, G. Shu, and E. A. Clark. 1994. CD40 and ils ligand in the regulation of humoral immunity. Semin. Immunol. 6:279.
40. Tian, L., R. J. Noelle, and D. A. Lawrence. 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306.
41. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
42. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669.
43. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to leishmania amazonensis infection. Immunity 4:263.
44. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
45. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
46. Durie, F., A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333.